Takara Bio, Inc. engages in development and marketing of genetic engineering technologies. The company is headquartered in Kusatsu-Shi, Shiga-Ken and currently employs 1,779 full-time employees. The company went IPO on 2004-12-07. The firm operates in three business segments. Bioindustry Support segment provides reagents for research (genetic engineering reagents, cell engineering reagents, protein engineering reagents), scientific instruments, contract services and license fees for gene related patents to research institutes, such as universities and companies where biotechnology research and development are conducted. Gene Medicine segment provides gene therapy-related development and sale licensing fees and trial products as an application field of genetic engineering technology and cell engineering technology which is core technology cultivated in development of research reagents. Medical Food and Biotechnology segment provides health food and health food research and development services, license fees for health food related patents, as well as license fees for mushrooms.
Follow-Up Questions
Qui est le CEO de Takara Bio Inc ?
Mr. Koichi Nakao est le President de Takara Bio Inc, il a rejoint l'entreprise depuis 2007.
Quelle est la performance du prix de l'action TKBIF ?
Le prix actuel de TKBIF est de $0, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Takara Bio Inc ?
Takara Bio Inc appartient à l'industrie Biotechnology et le secteur est Health Care
Quelle est la capitalisation boursière de Takara Bio Inc ?
La capitalisation boursière actuelle de Takara Bio Inc est de $NaN
Est-ce que Takara Bio Inc est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 5 analystes ont établi des notations d'analystes pour Takara Bio Inc, y compris 1 achat fort, 3 achat, 4 maintien, 0 vente et 1 vente forte
